Stay updated on Pembrolizumab Combo in Endometrial Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo in Endometrial Cancer Clinical Trial page.

Latest updates to the Pembrolizumab Combo in Endometrial Cancer Clinical Trial page
- Check4 days agoChange DetectedA new version (82) appears with a 2026-09-17 date, and the history includes a Study Status entry dated 2026-09-18, representing an update to the trial's current status in the record.SummaryDifference0.2%

- Check11 days agoChange DetectedA new revision entry v3.7.0 was added to the study record history. The previous revision v3.6.6 was removed, reflecting an update to the page's version history.SummaryDifference0.0%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe revision label in the page history changes from v3.6.5 to v3.6.6, indicating a new platform release in the history view.SummaryDifference0.0%

- Check46 days agoChange DetectedFooter now shows Revision: v3.6.5, replacing Revision: v3.6.4. This reflects a new site release.SummaryDifference0.0%

- Check61 days agoChange DetectedA new revision (v3.6.4) was posted on 2026-07-24, adding updates to the Study Status and Contacts/Locations sections of the record history. The previous revision (v3.6.3) from 2026-06-05 was superseded.SummaryDifference0.2%

- Check82 days agoChange DetectedThe Record History page now shows the latest revision as v3.6.3, replacing v3.6.2. This change represents a metadata-level update reflecting the page's rendering version.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab Combo in Endometrial Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Endometrial Cancer Clinical Trial page.